R, I., R, K., A, A., V, K., T, P., PH, C., . . . MG, K. (2020). Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer. American journal of therapeutics, 27(5), e500. https://doi.org/10.1097/MJT.0000000000000859
Chicago Style (17th ed.) CitationR, Islam, Khan R, Ali A, Kollu V, Phan T, Chyou PH, Burmester JK, and Kibriya MG. "Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer." American Journal of Therapeutics 27, no. 5 (2020): e500. https://doi.org/10.1097/MJT.0000000000000859.
MLA (9th ed.) CitationR, Islam, et al. "Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer." American Journal of Therapeutics, vol. 27, no. 5, 2020, p. e500, https://doi.org/10.1097/MJT.0000000000000859.
